187 related articles for article (PubMed ID: 27429708)
1. Alteration of Neutrophil Reactive Oxygen Species Production by Extracts of Devil's Claw (Harpagophytum).
Muzila M; Rumpunen K; Wright H; Roberts H; Grant M; Nybom H; Sehic J; Ekholm A; Widén C
Oxid Med Cell Longev; 2016; 2016():3841803. PubMed ID: 27429708
[TBL] [Abstract][Full Text] [Related]
2. Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein.
Romiti N; Tramonti G; Corti A; Chieli E
Phytomedicine; 2009 Dec; 16(12):1095-100. PubMed ID: 19577448
[TBL] [Abstract][Full Text] [Related]
3. Isolation and anti-inflammatory activity evaluation of triterpenoids and a monoterpenoid glycoside from Harpagophytum procumbens.
Qi J; Li N; Zhou JH; Yu BY; Qiu SX
Planta Med; 2010 Nov; 76(16):1892-6. PubMed ID: 20577946
[TBL] [Abstract][Full Text] [Related]
4. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro.
Abdelouahab N; Heard C
J Nat Prod; 2008 May; 71(5):746-9. PubMed ID: 18412394
[TBL] [Abstract][Full Text] [Related]
5. Harpagoside Content in Devil's Claw Extracts.
Kondamudi N; Turner MW; McDougal OM
Nat Prod Commun; 2016 Sep; 11(9):1215-1216. PubMed ID: 30807002
[TBL] [Abstract][Full Text] [Related]
6. The commercial harvest of devil's claw (Harpagophytum spp.) in southern Africa: the devil's in the details.
Stewart KM; Cole D
J Ethnopharmacol; 2005 Sep; 100(3):225-36. PubMed ID: 16112533
[TBL] [Abstract][Full Text] [Related]
7. The inhibition of free radical generation by preparations of Harpagophytum procumbens in vitro.
Grant L; McBean DE; Fyfe L; Warnock AM
Phytother Res; 2009 Jan; 23(1):104-10. PubMed ID: 18803229
[TBL] [Abstract][Full Text] [Related]
8. Devil's Claw-a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens.
Mncwangi N; Chen W; Vermaak I; Viljoen AM; Gericke N
J Ethnopharmacol; 2012 Oct; 143(3):755-71. PubMed ID: 22940241
[TBL] [Abstract][Full Text] [Related]
9. Toxicology studies of aqueous-alcohol extracts of Harpagophytum procumbens subsp. procumbens (Burch.) DC.Ex Meisn. (Pedaliaceae) in female and male rats.
Joshi K; Parrish A; Grunz-Borgmann EA; Gerkovich M; Folk WR
BMC Complement Med Ther; 2020 Jan; 20(1):9. PubMed ID: 32020872
[TBL] [Abstract][Full Text] [Related]
10. Cholinesterases inhibitory and antioxidant activities of Harpagophytum procumbens from in vitro systems.
Georgiev MI; Alipieva K; Orhan IE
Phytother Res; 2012 Feb; 26(2):313-6. PubMed ID: 21721061
[TBL] [Abstract][Full Text] [Related]
11. What the devil is in your phytomedicine? Exploring species substitution in Harpagophytum through chemometric modeling of 1H-NMR and UHPLC-MS datasets.
Mncwangi NP; Viljoen AM; Zhao J; Vermaak I; Chen W; Khan I
Phytochemistry; 2014 Oct; 106():104-115. PubMed ID: 25041697
[TBL] [Abstract][Full Text] [Related]
12. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay.
Anauate MC; Torres LM; de Mello SB
Phytother Res; 2010 Sep; 24(9):1365-9. PubMed ID: 20812280
[TBL] [Abstract][Full Text] [Related]
13. The Fight against Infection and Pain: Devil's Claw (
Gxaba N; Manganyi MC
Molecules; 2022 Jun; 27(11):. PubMed ID: 35684573
[No Abstract] [Full Text] [Related]
14. Quality Assessment of Commercial Spagyric Tinctures of
Avato P; Argentieri MP
Molecules; 2019 Jun; 24(12):. PubMed ID: 31212908
[TBL] [Abstract][Full Text] [Related]
15. Devil's Claw (Harpagophytum procumbens) as a treatment for osteoarthritis: a review of efficacy and safety.
Brien S; Lewith GT; McGregor G
J Altern Complement Med; 2006 Dec; 12(10):981-93. PubMed ID: 17212570
[TBL] [Abstract][Full Text] [Related]
16. Harpagophytum procumbens prevents oxidative stress and loss of cell viability in vitro.
Schaffer LF; Peroza LR; Boligon AA; Athayde ML; Alves SH; Fachinetto R; Wagner C
Neurochem Res; 2013 Nov; 38(11):2256-67. PubMed ID: 23982320
[TBL] [Abstract][Full Text] [Related]
17. Estimation of the relative antiinflammatory efficacies of six commercial preparations of Harpagophytum procumbens (Devil's Claw).
Ouitas NA; Heard C
Phytother Res; 2010 Mar; 24(3):333-8. PubMed ID: 19610038
[TBL] [Abstract][Full Text] [Related]
18. Assessment of diversity in Harpagophytum with RAPD and ISSR markers provides evidence of introgression.
Muzila M; Werlemark G; Ortiz R; Sehic J; Fatih M; Setshogo M; Mpoloka W; Nybom H
Hereditas; 2014 Oct; 151(4-5):91-101. PubMed ID: 25363276
[TBL] [Abstract][Full Text] [Related]
19. Alteration of anti-inflammatory activity of Harpagophytum procumbens (devil's claw) extract after external metabolic activation with S9 mix.
Hostanska K; Melzer J; Rostock M; Suter A; Saller R
J Pharm Pharmacol; 2014 Nov; 66(11):1606-14. PubMed ID: 25175765
[TBL] [Abstract][Full Text] [Related]
20. DNA Barcode Authentication of Devil's Claw Herbal Dietary Supplements.
Diaz-Silveira GL; Deutsch J; Little DP
Plants (Basel); 2021 Sep; 10(10):. PubMed ID: 34685813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
